AKT1 and neoplasm: Some results suggest that twist-related protein 1 (TWIST1)- and epithelial–mesenchymal transition (EMT)-driven increases in Akt activation, and thus tumour cell proliferation, as a potential mechanism of drug resistance in epithelial ovarian cancer [27].